Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
10 pending office actions • 4 art units • 7 examiners • 0 of 10 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Inbiose N V currently has 11 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 8 distinct examiners and 4 distinct art units. This volume of activity indicates ongoing interaction with the patent office. The distribution across 4 distinct art units suggests that the company's research and development efforts cover several specialized areas within the broader biotechnology field.
ROBINSON, HOPE A is the busiest examiner for this portfolio. This examiner is responsible for 2 pending office actions. With 8 distinct examiners managing the 11 pending actions, the company's prosecution strategy involves navigating the individual styles and requirements of a group of officials. The concentration of 11 actions within 4 distinct art units allows for technical review consistency, even as the work is spread among 8 distinct examiners. This profile requires a coordinated approach to ensure that arguments made across different cases remain consistent within the 4 distinct art units.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 3 (30%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 1 (10%) |
| Multi-statute (no §101) | 4 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, HOPE A | 2 | 67.7% | +43.1% |
| EIX, EMILY FAY | 2 | 45.5% | +78.3% |
| SPANGLER, JOSEPH RANKIN | 2 | 41.2% | +69.5% |
| JONES-FOSTER, ERICA NICOLE | 1 | 48.1% | +44.7% |
| MCKNIGHT, CIARA A | 1 | 60.8% | +38.8% |
| MONSHIPOURI, MARYAM | 1 | 79.1% | +37.5% |
| HOLLAND, PAUL J | 1 | 57.5% | +64.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17904189 | PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS | SPANGLER, JOSEPH RANKIN | 6d |
| 18261806 | PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS | EIX, EMILY FAY | 27d |
| 18579664 | LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES | JONES-FOSTER, ERICA NICOLE | — |
| 18167687 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | ROBINSON, HOPE A | — |
| 18041019 | METHOD TO PRODUCE A PURIFIED MIXTURE OF DIFFERENT OLIGOSACCHARIDES PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | MONSHIPOURI, MARYAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720533 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | ROBINSON, HOPE A | 52d overdue |
| 17904189 | PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS | SPANGLER, JOSEPH RANKIN | 6d |
| 17627088 | PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS | HOLLAND, PAUL J | 26d |
| 18261806 | PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS | EIX, EMILY FAY | 27d |
| 18579664 | LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES | JONES-FOSTER, ERICA NICOLE | — |
| 18041154 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | MCKNIGHT, CIARA A | — |
| 18167687 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | ROBINSON, HOPE A | — |
| 18041019 | METHOD TO PRODUCE A PURIFIED MIXTURE OF DIFFERENT OLIGOSACCHARIDES PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | MONSHIPOURI, MARYAM | — |
| Art Unit | Apps |
|---|---|
| 1656 | 5 |
| 1652 | 2 |
| 1653 | 2 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720533 | PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | 52d overdue | Pending | Jun 14, 2024 |
| 18579664 | LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES | JONES-FOSTER, ERICA NICOLE | 1656 | §102§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18041154 | CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES | MCKNIGHT, CIARA A | 1656 | §102§103§112DP | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18261806 | PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS | EIX, EMILY FAY | 1653 | §102§103§112Other | Final Rejection | 27d | Pending | Jul 17, 2023 |
| 18167687 | PRODUCTION OF GALACTOSYLATED DI- AND OLIGOSACCHARIDES | ROBINSON, HOPE A | 1652 | §102§112 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 18041019 | METHOD TO PRODUCE A PURIFIED MIXTURE OF DIFFERENT OLIGOSACCHARIDES PRODUCED BY CELL CULTIVATION OR MICROBIAL FERMENTATION | MONSHIPOURI, MARYAM | 1651 | §103§112Other | Non-Final OA | — | Pending | Feb 08, 2023 |
| 18041064 | PRODUCTION OF OLIGOSACCHARIDE MIXTURES BY A CELL | EIX, EMILY FAY | 1653 | §103 | Non-Final OA | — | Pending | Feb 08, 2023 |
| 17904189 | PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS | SPANGLER, JOSEPH RANKIN | 1656 | §101§102§112Other | Non-Final OA | 6d | Pending | Aug 12, 2022 |
| 17627088 | PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS | HOLLAND, PAUL J | 1656 | §103 | Final Rejection | 26d | Pending | Jan 13, 2022 |
| 17295688 | PRODUCTION OF 3-FUCOSYLLACTOSE AND LACTOSE CONVERTING ALPHA-1,3-FUCOSYLTRANSFERASE ENZYMES | SPANGLER, JOSEPH RANKIN | 1656 | §103Other | Final Rejection | — | Pending | May 20, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial